Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
I was diagnosed with multiple myeloma in early 1994. I underwent standard-of-care MM therapy including surgery, chemotherapy, radiation and an autologous stem cell transplant. I know live with several long-term and late stage multiple myeloma side effects. I supplement with and recommend Doctor’s Best N acetyl cysteine for several reasons.
According to ConsumerLabs.com NAC reduces symptoms and severity of the flu, may decrease the frequency and severity of chronic bronchitis and COPD, may lower homocysteine levels and may reduce the severity of certain mental health disorders. Also according to Consumerlab.com Doctor’s Best NAC Detox Regulators is the best value of all of the brands evaluated.
I am both a multiple myeloma survivor and MM cancer coach. Years of research and experience have taught me that evidence-based non-conventional therapies are available for everything from side effect prevention to cancer care and everything in between.
Have you been diagnosed with cancer? Please scroll down the page, post a question or comment and I will reply to you ASAP.
Hemorrhagic cystitis –Acetylcysteine has been used for cyclophosphamide-induced hemorrhagic cystitis, although mesna is generally preferred due to the ability of acetylcysteine to diminish the effectiveness of cyclophosphamide.
“Psychiatry-Acetylcysteine has been successfully tried as a treatment for a number of psychiatric disorders. A systematic review from 2015, and several earlier medical reviews, indicated that there is favorable evidence for N-acetylcysteine efficacy in the treatment of Alzheimer’s disease, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, schizophrenia,
“There is an expanding field of research investigating the benefits of medicines with multiple mechanisms of action across neurological disorders. N-acetylcysteine (NAC), widely known as an antidote to acetaminophen overdose, is now emerging as treatment of vascular and nonvascular neurological disorders. NAC as a precursor to the antioxidant glutathione modulates glutamatergic, neurotrophic, and inflammatory pathways…
Finally, we review the potential applications of NAC to facilitate recovery after traumatic brain injury, cerebral ischemia, and in treatment of cerebrovascular vasospasm after subarachnoid hemorrhage…”
“N-acetyl cysteine (NAC), as a nutritional supplement, is a greatly applied antioxidant in vivo and in vitro. NAC is a precursor of L-cysteine that results in glutathione elevation biosynthesis. It acts directly as a scavenger of free radicals, especially oxygen radicals.
NAC is a powerful antioxidant. It is also recommended as a potential treatment option for different disorders resulted from generation of free oxygen radicals. Additionally, it is a protected and endured mucolytic drug that mellows tenacious mucous discharges. It has been used for treatment of various diseases in a direct action or in a combination with some other medications…
Muscle performance- Investigations showed no effect of NAC on nonfatigued muscle, although after three minutes of repetitive contractions, it caused a considerably enhanced force output, up to approximately 15%. This means that NAC can improve muscle performance. This result is originated from the fact that oxidative stress plays a causal role in the fatigue process, since NAC is a scavenger of free radicals causing oxidative stress…
Alzheimer- Alzheimer disease (AD) is known as a multifactorial disease with many abnormalities in physiological, biochemical, and neurochemical point of view. Aging is the major risk factor for AD that coexists with other causes of cognitive decline, particularly vascular dementia (48)…
Parkinson- Parkinson disease (PD) is a very prevalent neurodegenerative disorder caused by unknown deterioration of cells which generate dopamine in the pars compacta, a part of the substantial nigra located in the midbrain (54)…